(Q33548096)

28 July 2017

title

When to start antiretroviral therapy in resource-limited settings: a human rights analysis (English)

1 reference

28 July 2017

main subject

anti-retroviral agent

0 references

0 references

2

Alexandra Calmy

1 reference

28 July 2017

1

Nathan Ford

1 reference

28 July 2017

Samia Hurst

3

1 reference

28 July 2017

publication date

31 March 2010

1 reference

BMC International Health and Human Rights

28 July 2017

published in

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

page(s)

6

1 reference

Creative Commons Attribution 2.0 Generic

28 July 2017

copyright license

start time

31 March 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Improving first-line antiretroviral therapy in resource-limited settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

When to start antiretroviral therapy in resource-limited settings

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Improvements in antiretroviral therapy outcomes over calendar time

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Efficacy and tolerability of initial antiretroviral therapy: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Antiretroviral therapy and early mortality in South Africa

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Vulnerability in research and health care; describing the elephant in the room?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

When should antiretroviral therapy for HIV be started?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Do we need a world health insurance to realise the right to health?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

CD4+ count-guided interruption of antiretroviral treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Ethics and SARS: lessons from Toronto

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Correlates of lending needles/syringes among HIV-seropositive injection drug users

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Highlights of the International AIDS Society Conference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Access to antiretroviral drugs in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Which patients first? Setting priorities for antiretroviral therapy where resources are limited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Exploring HIV risk perception and behaviour in the context of antiretroviral treatment: results from a township household survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Universal Access to HIV prevention, treatment and care: assessing the inclusion of human rights in international and national strategic plans

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

The run on tamiflu--should physicians prescribe on demand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Avian influenza and the failure of public rationing discussions

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-698X-10-6

Cost and cost-effectiveness of switching from stavudine to tenofovir in first-line antiretroviral regimens in South Africa

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

A case for integrating human rights in public health policy.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

What does social justice require for the public's health? Public health ethics and policy imperatives

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Can medical criteria settle priority-setting debates? The need for ethical analysis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2864209

Rationing influenza vaccine

31 October 2018

1 reference

12 December 2020

Health Systems and the Right to the Highest Attainable Standard of Health

1 reference

12 December 2020

HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population

1 reference

12 December 2020

Relations among CD4 Lymphocyte Count Nadir, Antiretroviral Therapy, and HIV-1 Disease Progression: Results from the EuroSIDA Study

1 reference

12 December 2020

US Senate passes new PEPFAR bill

1 reference

12 December 2020

Human rights and public health: dichotomies or synergies in developing countries? Examining the case of HIV in South Africa

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-698X-10-6

1 reference

Dimensions Publication ID

28 July 2017

1043332313

0 references

Fatcat ID

release_x3b6lx2e3zdebarhel4blss7vu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x3b6lx2e3zdebarhel4blss7vu

24 November 2022

mapped directly with Wikidata item

PMC publication ID

2864209

1 reference

28 July 2017

1 reference